Elsevier, The Lancet Global Health, Volume 10, January 2022
Background: Effectiveness of health programmes can be undermined when the implementation misaligns with local beliefs and behaviours. To design context-driven implementation strategies, we explored beliefs and behaviours regarding chronic respiratory disease (CRD) in diverse low-resource settings. Methods: This observational mixed-method study was conducted in Africa (Uganda), Asia (Kyrgyzstan and Vietnam) and Europe (rural Greece and a Roma camp). We systematically mapped beliefs and behaviours using the SETTING-tool.
Elsevier, The Lancet Regional Health - Western Pacific, Volume 18, January 2022
Background: Hepatitis C elimination may be possible with broad uptake of direct-acting antiviral treatments (DAAs). In 2016 the Australian government committed A$1.2 billion for five years of unlimited DAAs (March 2016 to February 2021) in a risk-sharing agreement with pharmaceutical companies. We assess the impact, cost-effectiveness and net economic benefits likely to be realised from this investment.
Elsevier,
Biomedical Engineering Applications for People with Disabilities and the Elderly in the COVID-19 Pandemic and Beyond, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the impact of the COVID-19 pandemic on the physical and mental health of the elderly.
Elsevier,
iPSCs - State of the Science
Volume 16 in Advances in Stem Cell Biology
2022, Pages 197-224
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on the uses of iPSCs in inherited diseases and, particularly, in the case of Gaucher disease (GD).
Elsevier,
Herbal Medicines: A Boon for Healthy Human Life, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring herbal medicines role in depression to provide alternatives to current psychiatric drugs which may cause many induced side effects.
Elsevier,
The Neuroscience of Autism, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing different levels and magnitude of explanation for the various behavioral symptoms seen in individuals with ASD, collectively providing a comprehensive picture of this disorder.
Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the evidence base for treatment of youth with depression, with a focus on management of treatment-resistant depression.
Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring novel and advanced personalized medicine approaches to tailor depression treatments.
Elsevier,
The Neuroscience of Autism, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the history and evolution of the definition and characterization of autism over the past several decades and the impact of it on how the disorder is perceived by autistic individuals, families, and professionals
Elsevier,
Artificial Intelligence, Machine Learning, and Mental Health in Pandemics: A Computational Approach, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting the design, execution, and test results of the dyslexia health management system; and highlighting the high potential for worldwide deployment using blockchain technology.